AvalehtBMY • NYSE
add
Bristol-Myers Squibb Co
Viimane sulgemishind
50,12 $
Aasta vahemik
39,35 $ - 58,46 $
Turuväärtus
101,61 mld USD
Keskmine maht
10,16 mln
P/E suhe
-
Dividendimäär
4,79%
Põhibörs
NYSE
Uudised
Finantsandmed
Kasumiaruanne
Käive
Puhastulu
| (USD) | juuni 2024info | Y/Y muutus |
|---|---|---|
Käive | 12,20 mld | 8,69% |
Põhitegevusega seonduv kulu | 6,63 mld | 3,25% |
Puhastulu | 1,68 mld | −18,96% |
Puhaskasumimarginaal | 13,77 | −25,45% |
Puhaskasum aktsia kohta | 2,07 | 18,29% |
EBITDA | 5,22 mld | 17,59% |
Tõhus maksumäär | −30,95% | — |
Bilansiaruanne
Kogu vara
Kõik kohustused
| (USD) | juuni 2024info | Y/Y muutus |
|---|---|---|
Sularaha ja lühiajalised investeeringud | 6,65 mld | −23,79% |
Kogu vara | 94,65 mld | 1,24% |
Kõik kohustused | 77,58 mld | 26,23% |
Kogu omakapital | 17,07 mld | — |
Emiteeritud aktsiate arv | 2,03 mld | — |
Hinna ja väärtuse suhe P/B | 5,97 | — |
Varade tasuvus | 6,71% | — |
Kapitali tasuvus | 8,95% | — |
Rahavoog
Raha ja raha ekvivalentide muutus
| (USD) | juuni 2024info | Y/Y muutus |
|---|---|---|
Puhastulu | 1,68 mld | −18,96% |
Põhitegevuse rahakäive | 2,33 mld | 23,26% |
Investeeringute raha | −1,32 mld | −300,91% |
Finantseerimise raha | −4,02 mld | −85,14% |
Raha ja raha ekvivalentide muutus | −3,04 mld | −387,64% |
Tasuta rahavoog | 2,61 mld | −2,24% |
Teave
The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company. Headquartered in Princeton, New Jersey, BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion.
Bristol Myers Squibb manufactures prescription pharmaceuticals and biologics in several therapeutic areas, including cancer, HIV/AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis, and psychiatric disorders.
BMS's primary research and development sites are located in Lawrence, New Jersey, Summit, New Jersey, formerly HQ of Celgene, New Brunswick, New Jersey, Redwood City, California, and Seville in Spain, with other sites in Devens and Cambridge, Massachusetts, Braine-l'Alleud, Belgium, Tokyo, Japan, Hyderabad; Bangalore India and Wirral, United Kingdom. BMS previously had an R&D site in Wallingford, Connecticut. Wikipedia
Tegevjuht
Asutatud
1887
Veebisait
Töötajate arv
34 100
